Horizon Therapeutics Plc

This committee provides the official 'revenue estimates' (scoring) required for all tax bills, directly influencing the final shape of tax legislation. This directly impacts the legal environment for corporate taxation, affecting profitability and investment decisions for companies like Horizon Therapeutics.

This is a powerful committee that controls taxation (corporate valuations), trade policy (global supply chains and market access), and entitlement spending (e.g., Medicare drug pricing), all of which directly and profoundly impact pharmaceutical company revenues, profitability, and legal environment.

This committee allocates discretionary federal spending. Its subcommittees directly determine the budgets for agencies like the FDA and NIH, and funding for major government healthcare programs (Medicare, Medicaid, VA) which are significant customers or regulatory bodies for pharma.

This committee directly regulates the FDA (drug approval and safety) and the NIH (biomedical research funding), which are paramount to the development, approval, and commercial viability of pharmaceutical products.

This committee oversees antitrust laws (crucial for M&A in pharma) and intellectual property rights (patents, fundamental to drug development and exclusivity), directly impacting the legal environment and profitability of pharmaceutical companies.